Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 277

1.

Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe.

Brown D, Canton R, Dubreuil L, Gatermann S, Giske C, MacGowan A, Martinez-Martinez L, Mouton J, Skov R, Steinbakk M, Walton C, Heuer O, Struelens M, Diaz Hogberg L, Kahlmeter G.

Euro Surveill. 2015 Jan 15;20(2). pii: 21008. No abstract available.

PMID:
25613780
[PubMed - in process]
Free Article
2.

The Strength of Synergistic Interaction between Posaconazole and Caspofungin depends on the Underlying Azole-Resistance Mechanism of Aspergillus fumigatus.

Mavridou E, Meletiadis J, Rijs A, Mouton JW, Verweij PE.

Antimicrob Agents Chemother. 2015 Jan 12. pii: AAC.04469-14. [Epub ahead of print]

PMID:
25583716
[PubMed - as supplied by publisher]
3.

Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosis.

Seyedmousavi S, Mouton JW, Melchers WJ, Verweij PE.

Antimicrob Agents Chemother. 2014 Dec 22. pii: AAC.03850-14. [Epub ahead of print]

PMID:
25534731
[PubMed - as supplied by publisher]
4.

Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.

Seyedmousavi S, Verweij PE, Mouton JW.

Expert Rev Anti Infect Ther. 2015 Jan;13(1):9-27. doi: 10.1586/14787210.2015.990382.

PMID:
25488140
[PubMed - in process]
5.

Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model-authors' response.

Siopi M, Mavridou E, Mouton JW, Verweij PE, Zerva L, Meletiadis J.

J Antimicrob Chemother. 2015 Feb;70(2):634-5. doi: 10.1093/jac/dku484. Epub 2014 Dec 8. No abstract available.

PMID:
25488075
[PubMed - in process]
6.

In vitro activity of combinations of ceftazidime-avibactam in in vitro checkerboard assays.

Berkhout J, Melchers MJ, van Mil AC, Nichols WW, Mouton JW.

Antimicrob Agents Chemother. 2014 Dec 8. pii: AAC.04146-14. [Epub ahead of print]

PMID:
25487794
[PubMed - as supplied by publisher]
7.

Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey.

Mouton JP, Mehta U, Parrish AG, Wilson DP, Stewart A, Njuguna CW, Kramer N, Maartens G, Blockman M, Cohen K.

Br J Clin Pharmacol. 2014 Dec 5. doi: 10.1111/bcp.12567. [Epub ahead of print]

PMID:
25475751
[PubMed - as supplied by publisher]
8.

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus.

Nation RL, Li J, Cars O, Couet W, Dudley MN, Kaye KS, Mouton JW, Paterson DL, Tam VH, Theuretzbacher U, Tsuji BT, Turnidge JD.

Lancet Infect Dis. 2014 Oct 21. pii: S1473-3099(14)70850-3. doi: 10.1016/S1473-3099(14)70850-3. [Epub ahead of print] Review.

PMID:
25459221
[PubMed - as supplied by publisher]
9.

Ascribing novel functions to the sarcomeric protein, myosin binding protein H (MyBPH) in cardiac sarcomere contraction.

Mouton J, Loos B, Moolman-Smook JC, Kinnear CJ.

Exp Cell Res. 2014 Nov 18. pii: S0014-4827(14)00495-9. doi: 10.1016/j.yexcr.2014.11.006. [Epub ahead of print]

PMID:
25449695
[PubMed - as supplied by publisher]
10.

Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration.

Laterre PF, Wittebole X, Van de Velde S, Muller AE, Mouton JW, Carryn S, Tulkens PM, Dugernier T.

J Antimicrob Chemother. 2014 Nov 27. pii: dku465. [Epub ahead of print]

PMID:
25433006
[PubMed - as supplied by publisher]
11.

Pharmacodynamics of Imipenem in Combination with MK7655, a Beta-Lactamase Inhibitor, in the Murine Thigh Model.

Mavridou E, Melchers RJ, van Mil AC, Mangin E, Motyl MR, Mouton JW.

Antimicrob Agents Chemother. 2014 Nov 17. pii: AAC.03706-14. [Epub ahead of print]

PMID:
25403667
[PubMed - as supplied by publisher]
12.

Time-kill kinetics of antibiotics active against rapidly growing mycobacteria.

Ferro BE, van Ingen J, Wattenberg M, van Soolingen D, Mouton JW.

J Antimicrob Chemother. 2014 Oct 25. pii: dku431. [Epub ahead of print]

PMID:
25344808
[PubMed - as supplied by publisher]
13.

Inhaled antibiotics: dry or wet?

Tiddens HA, Bos AC, Mouton JW, Devadason S, Janssens HM.

Eur Respir J. 2014 Nov;44(5):1308-18. doi: 10.1183/09031936.00090314. Epub 2014 Oct 16.

PMID:
25323242
[PubMed - in process]
14.

EUCAST testing of Isavuconazole susceptibility in Aspergillus: comparison of results for Inoculum standardization using Conidium counting versus optical density.

Arendrup MC, Howard S, Lass-Flörl C, Mouton JW, Meletiadis J, Cuenca-Estrella M.

Antimicrob Agents Chemother. 2014 Nov;58(11):6432-6. doi: 10.1128/AAC.03779-14. Epub 2014 Aug 18.

PMID:
25136005
[PubMed - in process]
15.

The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.

Seyedmousavi S, Mouton JW, Melchers WJ, Brüggemann RJ, Verweij PE.

Drug Resist Updat. 2014 Jul;17(3):37-50. doi: 10.1016/j.drup.2014.06.001. Epub 2014 Jul 5.

PMID:
25066814
[PubMed - in process]
16.

Polymorphisms in cytokine genes IL6, TNF, IL10, IL17A and IFNG influence susceptibility to complicated skin and skin structure infections.

Stappers MH, Thys Y, Oosting M, Plantinga TS, Ioana M, Reimnitz P, Mouton JW, Netea MG, Joosten LA, Gyssens IC.

Eur J Clin Microbiol Infect Dis. 2014 Dec;33(12):2267-74. doi: 10.1007/s10096-014-2201-0. Epub 2014 Jul 15.

PMID:
25022448
[PubMed - in process]
17.

[Therapeutic drug monitoring of antimicrobials].

Mouton JW, Aarnoutse RE.

Ned Tijdschr Geneeskd. 2014;158:A7520. Dutch.

PMID:
24988163
[PubMed - in process]
18.

Black yeasts and their filamentous relatives: principles of pathogenesis and host defense.

Seyedmousavi S, Netea MG, Mouton JW, Melchers WJ, Verweij PE, de Hoog GS.

Clin Microbiol Rev. 2014 Jul;27(3):527-42. doi: 10.1128/CMR.00093-13.

PMID:
24982320
[PubMed - in process]
19.

Isolation of ciprofloxacin-resistant Legionella pneumophila in a patient with severe pneumonia.

Bruin JP, Koshkolda T, IJzerman EP, Lück C, Diederen BM, Den Boer JW, Mouton JW.

J Antimicrob Chemother. 2014 Oct;69(10):2869-71. doi: 10.1093/jac/dku196. Epub 2014 Jun 4. No abstract available.

PMID:
24898020
[PubMed - in process]
20.

Combination therapy for carbapenem-resistant Gram-negative bacteria.

Paul M, Carmeli Y, Durante-Mangoni E, Mouton JW, Tacconelli E, Theuretzbacher U, Mussini C, Leibovici L.

J Antimicrob Chemother. 2014 Sep;69(9):2305-9. doi: 10.1093/jac/dku168. Epub 2014 May 28.

PMID:
24872346
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk